SIRT1

SIRT1 Promoter Variant — Expression Tuning at the Master Longevity Switch

SIRT1 (Sirtuin 1) is often called the master regulator of aging biology. This NAD+-dependent protein deacetylase | an enzyme that removes acetyl groups from proteins in a reaction that consumes NAD+, coupling cellular energy status to gene regulation coordinates DNA repair, inflammation suppression, mitochondrial biogenesis, insulin sensitivity, and stress resistance across virtually every tissue. rs3758391 lies approximately 2 kb upstream of the SIRT1 transcription start site — in the promoter region that determines how much SIRT1 protein the cell makes.

The Mechanism

The T allele at rs3758391 is associated with higher SIRT1 mRNA and protein expression, while the common C allele is associated with a more moderate expression level. The AMD study by Kaikaryte et al. | Kaikaryte K et al. SIRT1: Genetic Variants and Serum Levels in Age-Related Macular Degeneration. Life (Basel). 2022 found that individuals carrying at least one T allele had significantly elevated serum SIRT1 levels compared with CC homozygotes. This might seem paradoxical given that SIRT1 is generally considered protective in aging — but the relationship between SIRT1 expression level and disease risk is not linear. Chronically elevated SIRT1 can disrupt normal cell-cycle checkpoints in proliferating cells, contributing to cancer susceptibility, while the same elevated SIRT1 may benefit post-mitotic tissues like neurons.

The rs3758391 promoter variant is part of a broader regulatory haplotype that includes rs3818292 (intron 1) and rs7895833 (intron 5). The G-T-G combination across these three sites modulates SIRT1 expression in a tissue- and age-specific manner.

The Evidence

Cognitive aging: The Leiden 85-plus study | Kuningas M et al. SIRT1 gene, age-related diseases, and mortality: the Leiden 85-plus study. J Gerontol A Biol Sci Med Sci. 2007 followed 1,245 very elderly participants and found that T allele carriers showed better cognitive functioning and a trend toward lower cardiovascular mortality. A Han Chinese aging cohort | Zhang WG et al. SIRT1 variants are associated with aging in a healthy Han Chinese population. Clin Chim Acta. 2010 of 482 individuals (246 aged 60–91 years) found the C allele OR=1.453 (p=0.026) and CC genotype OR=3.042 (p=0.027) were more prevalent in older participants, interpreted as the C allele correlating with reaching old age — suggesting C carriers have lower cumulative disease burden over decades.

Metabolic protection: A large Iranian study by Naseri et al. 2024 | Naseri R et al. Protective role of SIRT1 (rs3758391 T>C) polymorphism against T2DM and its complications: Influence on GPx activity. Health Sci Rep. 2024 (n=398) found the C allele protective against type 2 diabetes, diabetic neuropathy, and diabetic retinopathy. CC and TC genotypes showed significantly higher glutathione peroxidase (GPx) activity than TT carriers, suggesting the C allele promotes antioxidant capacity. A Bangladeshi case-control study with meta-analysis by Ahmed et al. 2025 | Ahmed R et al. Association of SIRT1 rs3758391 Polymorphism With T2DM in Bangladeshi Population. Health Sci Rep. 2025 found TT vs CC OR=3.88 (95% CI 1.34–11.25) for T2DM, with the T allele carrying 1.67-fold higher odds (95% CI 1.07–2.60).

Cancer risk: In a Chinese cohort of 206 DLBCL lymphoma patients, Kan et al. 2018 | Kan Y et al. SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population. Cancer Cell Int. 2018 found TT carriers had OR=3.518 (95% CI 1.68–7.39) for disease and the TT genotype was an independent poor prognostic factor (HR=1.981, p=0.006). A Greek study by Papantzimas et al. 2026 | Papantzimas I et al. Association between SIRT1 rs3758391 genetic variant and susceptibility to pancreatic and gastric cancer. Ann Gastroenterol. 2026 found TC genotype protective against pancreatic cancer (OR=0.35, p=0.004) and gastric cancer (OR=0.26, p=0.006), with C allele enriched in healthy controls (OR=0.39, p<0.001).

Survival: A large Russian cohort of 3,312 individuals by Erdman et al. 2025 | Erdman V et al. Genetic predictors of longevity and survival in cellular homeostasis genes. Gene. 2025 found TT genotype associated with improved survival in diabetes patients (HR=0.40, p=0.006) and multimorbidity (HR=0.48, p=0.025) — suggesting TT carriers who do develop chronic disease fare better once ill, perhaps due to elevated SIRT1-mediated stress resistance.

Contradictions in the literature reflect SIRT1's tissue- and context-specific biology. The T allele's higher SIRT1 expression may benefit neurons and stressed tissues (cognitive protection, survival under disease) while heightening cancer susceptibility through disrupted cell-cycle control. The C allele's lower expression appears to reduce metabolic disease risk and improve antioxidant tone over decades.

Practical Implications

For TT carriers, supporting SIRT1 function through upstream inputs — adequate NAD+ availability, caloric sufficiency, and polyphenol intake — remains important, while cancer screening vigilance gains additional relevance. For CC carriers, the genetic architecture already provides metabolic protection; attention to maintaining the antioxidant advantages (GPx activity) through adequate selenium and zinc intake (cofactors for GPx enzymes) reinforces what the genotype already provides.

Interactions

rs3758391 participates in the rs3818292-rs3758391-rs7895833 three-variant SIRT1 haplotype. The G-T-G combination across these sites was associated with increased odds of exudative age-related macular degeneration in the Lithuanian cohort. rs3758391 also appears in haplotype combinations associated with depression comorbidity in T2DM (PMID 39612426). The full range of SIRT1 regulatory effects requires considering all three regulatory variants together, since each modulates expression through different promoter and intronic elements. The companion SNP rs7895833 is already profiled in the GeneOps database.